Innovative Health Solutions: NSS-2 Bridge Elektrostimulyator

At the end November, 2017 it became known of entry into the market of an electrostimulator for decrease in symptoms of drug addiction of NSS-2 Bridge (Neurostimulation System) developed by the American company Innovative Health Solutions.

The first device for decrease in symptoms of drug addiction enters the market

The device which fastens behind an ear sends signals to separate parts of a brain, stimulating with that specific areas for reduction of symptoms of an opioid abstinence syndrome.

Electrodes are applied to electric stimulation of group of occipital and cranial nerves (V, VII, IX, and X) which should help addicts to avoid excitation and other symptoms which appear after they get rid of use of opioids.

The Food and Drug Administration (FDA) approved NSS-2 Bridge to sale after publication of the research which showed that 73 patients to an opioid abstinence syndrome had a reduction of symptoms (among them — perspiration, a tremor, diarrhea, joint pain and concern) at least for 31% in half an hour after the beginning of use of this adaptation. Besides, 64 of 73 patients could switch to medicamentous therapy in five days of application of NSS-2 Bridge.

In October, 2017 the commissioner of FDA Scott Gottlieb said that the regulator will encourage wide use among drug-addicted less dangerous opioids, such as methadone and buprenorphine.

People who stop doing drugs test so-called "withdrawal pains" or an abstinence syndrome for a long time. How strongly and as long it will be shown, depends, first of all, from psychoactive substance — it influences also the subsequent drug treatment. NSS-2 Bridge is the remedy for an opioid syndrome which is not causing dependence, Scott Gottlieb noted.^[1]

Notes